GHK-Cu Peptide
US$ 26.95
aod9604 powder manufacturer AOD-9604 AOD 9604: Peptide Claims vs
Description
It has been studied for its potential applications in research, particularly in reducing reperfusion injury after tissue ischemia and mitigating metabolic disorders
It should not be used in pregnant or breastfeeding individuals, those with active cancer, or anyone with severe kidney or liver disease
Age Ageing 2007;36:177-83
Super quick and easy
Yes, **E55.9** can be reported with **malnutrition (E46)**, **hypocalcemia (E53.51)**, or **osteoporosis (M81.0)** provided there is a clinical rationale for the linkage 5
